{"id":"capre","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Constipation"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Abdominal pain"}]},"_chembl":null,"_dailymed":{"setId":"e5721cb8-4185-47b9-bbb3-1c587e558a03","title":"CAPRELSA (VANDETANIB) TABLET, FILM COATED [GENZYME CORPORATION]"},"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by inhibiting the absorption of cholesterol in the small intestine, thereby reducing the amount of cholesterol available to enter the bloodstream. This leads to a decrease in low-density lipoprotein (LDL) cholesterol levels, often referred to as 'bad' cholesterol.","oneSentence":"CaPre is a prescription medication used to lower cholesterol levels.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:44:05.033Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypercholesterolemia"}]},"trialDetails":[{"nctId":"NCT03361501","phase":"PHASE3","title":"A Phase 3 STudy of CaPRe in LOwering Very hiGh TriglYcerides (TRILOGY 2)","status":"COMPLETED","sponsor":"Grace Therapeutics Inc.","startDate":"2018-02-01","conditions":"Hypertriglyceridemia","enrollment":278},{"nctId":"NCT03398005","phase":"PHASE3","title":"A Phase 3 STudy of CaPRe In LOwering Very hiGh TriglYcerides (TRILOGY 1)","status":"COMPLETED","sponsor":"Grace Therapeutics Inc.","startDate":"2018-01-23","conditions":"Hypertriglyceridemia","enrollment":256},{"nctId":"NCT01455844","phase":"PHASE2","title":"TRIal For Efficacy of Capre on hyperTriglyceridemiA","status":"COMPLETED","sponsor":"Grace Therapeutics Inc.","startDate":"2011-09","conditions":"Hypertriglyceridemia","enrollment":387},{"nctId":"NCT01516151","phase":"PHASE2","title":"Assess the Safety and Efficacy of NKPL66 (CaPre™) in the Treatment of Mild-to-high Hypertriglyceridemia","status":"COMPLETED","sponsor":"Grace Therapeutics Inc.","startDate":"2011-12","conditions":"Hypertriglyceridemia","enrollment":289}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"CaPre","genericName":"CaPre","companyName":"Grace Therapeutics Inc.","companyId":"grace-therapeutics-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CaPre is a prescription medication used to lower cholesterol levels. Used for Hypercholesterolemia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}